AGIO:NASDAQ
Agios Pharmaceuticals Inc
37,00 USD
0,00%
(0,00) 1 d.
23. 10., 16:00:01 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre AGIO…
Trh. kap.
2,21 mld.
Priem. obj.
1,17 mil.
Objem
581,00
Max. za 52 týž.
46,00 USD
Min. za 52 týž.
22,24 USD
Výnosy na akciu
-7,01 USD
Beta
0,63
Akcie v obehu
59,70 mil.
Počet zamestnancov
540
Trh. kap.
2,21 mld.
Priem. obj.
1,17 mil.
Objem
581,00
Max. za 52 týž.
46,00 USD
Min. za 52 týž.
22,24 USD
Výnosy na akciu
-7,01 USD
Beta
0,63
Akcie v obehu
59,70 mil.
Počet zamestnancov
540
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 45 minútami
Syntec Optics (Nasdaq: OPTX) Doubles Production for Commercial Satellite Laser Optics to Meet Surging Space Demand
Seeking Alpha
·
pred 59 minútami
From worst to first? These battered S&P 500 stocks bounce back (SP500:)
MarketWatch
·
pred 1 hodinou
The stock market’s biggest test in weeks is here
Reuters
·
pred 2 hodinami
Mapping the Market: Nasdaq losing its grip on rally
Profil
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Informácie o subjekte Agios Pharmaceuticals Inc